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Summary
Background Zoster vaccination was introduced in England in 2013, where tackling
health inequalities is a statutory requirement. However, specific population
groups with higher zoster burden remain largely unidentified.
Objectives To evaluate health inequalities in zoster disease burden prior to zoster
vaccine introduction in England.
Methods This population-based cohort study used anonymized U.K. primary care
data linked to hospitalization and deprivation data. Individuals aged ≥ 65 years
without prior zoster history (N = 862 470) were followed from 1 September
2003 to 31 August 2013. Poisson regression was used to obtain adjusted rate
ratios (ARRs) for the association of sociodemographic factors (ethnicity, immi-
gration status, individuals’ area-level deprivation, care home residence, living
arrangements) with first zoster episode. Possible mediation by comorbidities and
immunosuppressive medications was also assessed.
Results There were 37 014 first zoster episodes, with an incidence of 879 [95%
confidence interval (CI) 870–888] per 1000 person-years at risk. In multivari-
able analyses, factors associated with higher zoster rates included care home resi-
dence (10% higher vs. those not in care homes), being a woman (16% higher
vs. men), nonimmigrants (~30% higher than immigrants) and white ethnicity
(for example, twice the rate compared with those of black ethnicity). Zoster inci-
dence decreased slightly with increasing deprivation (ARR most vs. least deprived
096 (95% CI 092–099) and among those living alone (ARR 096, 95% CI
094–098). Mediating variables made little difference to the ARR of social factors
but were themselves associated with increased zoster burden (ARR varied from
111 to 384).
Conclusions The burden of zoster was higher in specific sociodemographic groups.
Further study is needed to ascertain whether these individuals are attending for
zoster vaccination.
What’s already known about this topic?
• Monitoring and reducing health inequalities is a statutory requirement in the U.K.
• Incidence of herpes zoster is known to be higher among individuals with certain
comorbidities and those taking immunosuppressive treatment.
• In contrast, little is known about the social determinants of zoster, which may con-
tribute to the inequality of zoster disease burden in England.
What does this study add?
• Older individuals at higher risk of zoster included women, those in care homes,
those of white ethnicity and nonimmigrants.
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• Individuals with certain comorbidities and taking immunosuppressive therapies
were at appreciable increased risk of zoster, but this explained little of the
increased risk in the specific demographic and social groups.
• The findings should inform possible future use of the inactivated zoster vaccine
among those at higher risk, including care home residents.
Herpes zoster is associated with appreciable morbidity, and
postherpetic neuralgia (PHN, its commonest complication)
can be an incapacitating condition.1,2 Zoster can be precipi-
tated by immunosenescence or suppression of cell-mediated
immunity, and incidence increases with age, with rates vary-
ing from 6–8 per 1000 person-years to 8–12 per 1000 per-
son-years among those aged 60 and 80 years, respectively.1–5
Antiviral medications may limit zoster symptoms but their
effect on PHN remains uncertain.6 A single-dose vaccine that
is effective in preventing zoster and PHN was introduced in
the U.K. in 2013, targeting individuals aged 70–79 years.7–10
The effect of sociodemographic factors on zoster incidence
has not been extensively investigated. Older individuals and
those of white ethnicity have been shown to be at higher risk
of zoster.4,11,12 The association with other sociodemographic
factors such as sex, country of birth, marital status and socio-
economic status has been inconclusive.3–5,12–14 The unequal
distribution of zoster between social groups could potentially
be exacerbated by differential uptake of zoster vaccination,
resulting in even higher disease burden among some older
individuals. Identifying social groups at higher zoster risk is
therefore essential for planning preventative interventions to
mitigate inequalities of zoster burden and promote healthy
ageing across the population.
In England, zoster incidence trends are monitored using
general practice data to assess the impact of the vaccination
programme, but apart from sex no other social factors are
being evaluated.15 We have shown that some of these factors
can be ascertained using routinely collected electronic health
records such as the Clinical Practice Research Datalink
(CPRD),16 one of the world’s largest anonymized primary care
data sources.17
The aim of this cohort study was to determine the associa-
tion of sociodemographic factors with zoster incidence in Eng-
land using linked CPRD data in the period immediately before
zoster vaccine introduction, to inform suitable targeted vacci-
nation strategies.
Patients and methods
Data sources
This study used anonymized CPRD data linked to hospitaliza-
tion and deprivation data. CPRD provides quality-assured clini-
cal, lifestyle, demographic and administrative data, for a
representative sample of ~7% of the U.K. population.17–19 The
validity of recorded diagnoses within the database is generally
high.18 In England, CPRD provides linkages at an individual level
with other data, including hospitalization [Hospital Episode
Statistics (HES)] and deprivation data, for ~75% of practices.17,18
The deprivation data were based on a patient’s area of residence
and/or practice location [Index of Multiple Deprivation (IMD): a
composite small area-level score].17,18
Study population and follow-up
This cohort study spanned the 10-year period (1 September
2003 to 31 August 2013) prior to zoster vaccine introduction.
The study population comprised patients aged ≥ 65 years who
were registered with a CPRD practice in England during the
study period and eligible for linkage. Patients with zoster or
PHN codes prior to start of follow-up, or whose first zoster
code during follow-up was PHN, were identified in CPRD and
HES [using Read codes for CPRD and International Classifica-
tion of Disease (ICD) 10th revision codes for HES,
Appendix S1] and excluded.
Follow-up started on the latest of the following: study start
date (1 September 2003); 1 year after current registration date
(to avoid retrospective recording of past zoster in first few
months of new registration);20 the date the practice met
CPRD’s quality criteria;18 or individuals’ 65th birthday. Fol-
low-up ended on the earliest of the following: study end date
(31 August 2013); zoster date; transfer-out date; last collec-
tion date from the practice; or date of death.
Outcome
Incident zoster cases were defined as the first diagnostic code
for zoster during follow-up, using both CPRD and HES data
(Appendix S1; see Supporting Information). In the HES data,
patients with zoster codes in either the primary or the sec-
ondary diagnosis fields were included, and the hospital epi-
sode start date was used as the date of zoster.
Exposures
A conceptual framework (Appendix S2), based on the World
Health Organization’s Commission on Social Determinants of
Health framework, was hypothesized for the association of
individual-level sociodemographic factors with zoster inci-
dence.21 These factors included immigration status, religion,
ethnicity, deprivation, care home residence, marital status,
cohabitation (individuals living as a couple) and living alone.
The latter three factors provided overlapping information
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about an individual’s living arrangements. The code lists and
details of how these factors were identified in linked CPRD
data are provided in Appendices S3 and S4. The following fac-
tors were categorized as binary variables: being an immigrant
to the U.K., care home residence, cohabitation and living
alone. Marital status had six categories: single, married, wid-
owed, divorced, separated, and uncategorized/other partner.
Religion and ethnicity had eight (Christian, Buddhist, Hindu,
Jewish, Muslim, Sikh, other and no religion) and five (white,
south Asian, black, other and mixed) categories, respectively.
Social factors that changed with time such as marital status,
cohabitation, living alone and care home residence were time-
updated over the study period.
IMD data were available at both individual- and practice-
small area-level as quintiles [1 (least deprived) to 5 (most
deprived)]; individuals with missing IMD data were assigned
their practice’s IMD quintile.
Other variables
Based on previous data22 and the U.K. Green Book10 guidance
for immunosuppressive conditions considered to be a con-
traindication to live zoster vaccination, certain predisposing
conditions and immunosuppressive medications were postu-
lated as mediators between sociodemographic factors and zoster
incidence (Appendix S2). Conditions identified in either CPRD
or HES (Appendix S3) that were considered immunosuppressive
from the time of recorded diagnosis included rheumatoid
arthritis, systemic lupus erythematosus, inflammatory bowel
disease, diabetes mellitus, chronic kidney disease, chronic
obstructive pulmonary disease, asthma, human immunodefi-
ciency virus infection, other cellular immune deficiency and
solid organ transplant. Individuals with haematopoietic stem
cell transplant, leukaemia, lymphoma, myeloma and other
plasma cell dyscrasias were considered to be immunosuppressed
for 24 months following each record.22 Information on
immunosuppressive medications was extracted using previously
described methodology.22 Details for identifying immunosup-
pressive conditions and treatments in these data are provided in
Appendices S4–5. All putative mediating variables were catego-
rized as binary variables. Age was categorized in 5-yearly bands
from 65 to 84 years, with a final category of ≥ 85 years. The
study period was divided into five approximately equal cate-
gories to observe any temporal changes in zoster incidence.
Analyses
For all sociodemographic factors, the person-time at risk,
number of first zoster cases and missing values were tabulated.
Zoster incidence rates for each factor were obtained by divid-
ing the number of zoster cases by the person-time at risk. The
demographic characteristics of individuals with a past history
of zoster excluded from the study were compared with indi-
viduals included in the study.
Poisson regression was used to estimate incidence of the first
zoster episode and 95% confidence intervals (CI). Hypothesis
testing was conducted using likelihood ratio tests unless other-
wise stated. Age, sex and calendar period were considered as a
priori confounders; age and sex were also considered as risk
factors in their own right. The effect estimates for all explana-
tory and hypothesized mediating variables were first examined
after adjusting for the three a priori confounders in a mini-
mally adjusted model. A hierarchical approach to causal mod-
elling, based on the hypothesized causal framework between
the factors of interest, was then adopted for multivariable anal-
yses (Appendix S6).23 The first multivariable model included
the a priori confounders, ethnicity and immigration status
(model 1); patient-level IMD was then added (model 2), fol-
lowed by care home residence and living alone status (model
3). The potential mediating effects of comorbidities and thera-
peutic agents were examined in models 4 and 5, respectively.
Collinearity between closely related factors (for example living
arrangements) was assessed by comparing measures of effect
and log standard errors of the coefficient in minimally adjusted
and multivariable models. For multivariable models, individu-
als with complete covariate data were analysed. Data were anal-
ysed using the Stata 14 software package (StataCorp, College
Station, TX, U.S.A.).
Ethics
The protocol for this research was approved by the Indepen-
dent Scientific Advisory Committee (ISAC) for Medicines and
Healthcare products Regulatory Agency Database Research
(protocol number 16_168) and made available to the journal
and reviewers during peer review. The study was also
approved by the Observational/Interventions Research Ethics
Committee of the London School of Hygiene and Tropical
Medicine (Reference: 11910).
Results
The cohort initially included 931 830 individuals (Fig. 1)
from 385 practices across England, of which 69 360 were
excluded because of a prior history of zoster. The demo-
graphic characteristics of patients with and without a prior
zoster history (excluded and included, respectively, in the
study) are presented in Appendix S7. Those with a previous
history of zoster were likely to be older at the start of the
study (1 September 2003), women, nonimmigrants and indi-
viduals of white ethnicity, but were similar to included indi-
viduals with respect to IMD quintiles.
The median follow-up time for the eligible study cohort
(N = 862 470) was 433 [interquartile range (IQR)182–807]
years. More than half of the eligible study population were
women and were aged 65–69 years at the start of follow-up
(Table S1; see Supporting Information). Data were missing for
four variables: religion (98% missing), marital status (47%
missing), ethnicity (175% missing) and sex (< 001% missing)
(Table S1). For < 01% of the study population (n = 849), the
missing values of patient-level IMD were replaced by practice-
level IMD (Table S1).
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In total, 37 014 individuals experienced a first zoster epi-
sode during follow-up, the median age at zoster was
757 years (IQR 702–818 years) and the incidence was
879 (95% CI 870–888) per 1000 person-years at risk
(Table S1). The unadjusted zoster rates for all sociodemo-
graphic factors and mediating variables are presented in
Table S1.
A decision was made to drop the two variables with appre-
ciable missing data (religion and marital status) from further
analyses. Ethnicity and sex were retained in the analysis but
individuals with missing data were dropped. The complete
case analysis included 711 590 patients, after dropping partic-
ipants with missing data on ethnicity (n = 150 878) and/or
sex (n = 2) (Fig. 1). Demographic characteristics of individu-
als with and without missing ethnicity data are provided in
Appendix S8. Those without ethnicity data were similar to
those included in the analysis with only slightly lower zoster
incidence and marginally fewer comorbidities (Appendix S8).
In the minimally adjusted model (adjusted for age, sex and
calendar period, Table S2), zoster rates increased linearly with
age, the adjusted rate ratios (ARRs) in the oldest age groups
(aged ≥ 85 years) being 40% higher than for those aged 65–-
69 years. There was little evidence of changing incidence over
the study period. For the sociodemographic factors of interest,
men, those who were of non-white ethnicity, immigrants,
those living in more deprived areas (at the practice or patient-
level) and those living alone had lower rates of zoster, with
reduced rates of between 5% (for moderate deprivation at the
patient-level) to 53% (for black ethnicity) (all P-values
< 0001). Care home residents had higher zoster incidence
(ARR 112, 95% CI 106–118) than non-care home residents.
As expected, most of the comorbidities and all immunosup-
pressive treatments were associated with higher zoster inci-
dence (Table S2).
After adjusting for immigration status in addition to the
a priori confounders (model 1), the effect of ethnicity was
Patients aged ≥ 65 years during study period 01/09/2003-31/08/2013 registered with a CPRD 
practice and meeting the data quality assessment criteria
N = 931 830
Total patients included in the study  
N = 862 470
Patients with zoster code prior to start of follow-upa or with a 
first zoster code during follow up recorded as PHN
N = 69 360
Multivariable analyses: complete case analysis with non-missing data for all exposure variables 
(except for religion and marital statusb) 
N = 711 590
Patients with missing data for ethnicity and /or gender excluded 
N = 150 880
[Ethnicity (n = 150878), gender (n = 1) and both ethnicity and 
gender (n = 1)]
Fig 1. Study participants flow chart. aFollow-up started on the latest of the following: study start date (1 September 2003); 1 year after current
registration date; the date the practice met CPRD’s quality criteria; or individuals’ 65th birthday. Follow-up ended on the earliest of the following:
study end date (31 August 2013); zoster date; transfer-out date; last collection date from the practice; or date of death. bBoth these variables were
excluded from the analyses. CPRD, Clinical Practice Research Datalink; PHN, post-herpetic neuralgia.
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almost unchanged, with each non-white ethnic group remain-
ing at lower risk of zoster [ranging from a 15% reduced rate
(other ethnicity) to a 51% reduced rate (black ethnicity),
Table S2]. In contrast, the effect estimate for immigration status
was slightly attenuated after additionally adjusting for ethnicity,
although immigrants remained at 23% lower risk of zoster.
Practice- and patient-level deprivation were closely correlated,
as were living alone and cohabitation status; thus, only patient-
level IMD was added to model 2 and living alone to model 3.
There were no appreciable changes in the effect estimates for
each factor with successive adjustment (Table S2). Those living
in a care home had about a 10% higher rate of zoster, and those
living alone a reduced rate of 4% (model 3, Table S2). None of
the factors appeared to be mediated by comorbidities or
immunosuppressive therapies (models 4 and 5, Table S2).
When analyses were repeated for those with missing ethni-
city data, effect estimates in the minimally adjusted analysis
were all in the same direction of the main analysis
(Appendix S9). In further sensitivity analyses, restriction to
those of white ethnicity also showed no differences to the
main analysis (Appendix S10). Substitution of practice- for
patient-level IMD (Appendix S11) and cohabitation instead of
living alone (Appendix S12) also did not change the findings.
Discussion
In this large population-based cohort study, sociodemographic
factors independently associated with higher zoster risk
included age, female sex, white ethnicity and care home resi-
dence. There was little evidence of increased incidence among
minority ethnic groups, those living alone or living in
deprived areas. As in previous studies, increasing age, specific
comorbidities and immunosuppressive treatments were associ-
ated with higher zoster incidence.
This study used one of the world’s largest quality-assured pri-
mary care databases, linked to hospitalization and social depriva-
tion data, and provided data for a wide range of social factors,
including potential mediating variables for zoster risk. These
results could be potentially generalizable to older individuals
without prior history of zoster from countries with universal
access to health care as in the U.K. Ascertainment of social factors
using routinely collected electronic health records was achieved
by using detailed coding algorithms and rigorous methodology.
Causal modelling based on a predefined conceptual framework
ensured quantification of robust effect estimates.
The limitations associated with use of routinely collected
data included potential misclassification of both exposure and
outcome. Time-varying exposures such as living alone may be
misclassified in these data if not updated in a timely manner
in general practitioner records. Similarly, for binary variables,
the assumption that absence of a code implies absence of the
characteristic may not be true. However, the methods used in
this study are based on our previously developed methodology
for ascertainment of social factors among older individuals
using linked CPRD data, which found prevalence of factors
such as ethnicity, living alone, cohabitation and care home
residence comparable with the 2011 English Census, whereas
being an immigrant was under-represented in these data.16 In
the U.K., zoster is mainly diagnosed clinically;22 however, a
clinical diagnosis of zoster in primary care is reported to have
a high (91%) positive predictive value among older individu-
als.24 Any misclassification of exposure or outcome is likely to
be nondifferential, tending to bias effect estimates towards the
null. Thus, the actual effect estimates may be even larger than
observed here.
Differential zoster ascertainment in different social groups is
a consideration. For example, it is possible that those living
alone or in more deprived areas may not seek care for zoster.
Those seeking ongoing care for their comorbidities may have
a higher opportunity of zoster diagnosis, although we found
no mediating effect of comorbidities for any of the social fac-
tors examined. A previous U.S. study reported that 95% of
older individuals were likely to consult for zoster, irrespective
of sociodemographic characteristics such as income or marital
status.25 Unavailability of factors such as education, income
and social class, and poor recording of religion (2%) and mar-
ital status (~50%) in these data precluded the assessment of
their association with zoster in this study. Finally, excluding
individuals with missing ethnicity data could have biased our
results, but further multivariable and sensitivity analyses
showed no evidence for this.
The rates in this study are comparable with previously
reported zoster rates of 6–8 per 1000 person-years and 8–12
per 1000 person-years among individuals aged 60 and
80 years, respectively.2 However, the overall incidence of first
zoster episodes in this study of individuals aged ≥ 65 years
was slightly higher than a U.K.-based study of only immuno-
competent individuals that reported zoster rates of 596 (aged
65–69 years) to 622 (aged ≥ 85 years) per 1000 person-
years.26
Increasing age and female sex are both known to be associ-
ated with higher zoster incidence owing to age- and
sex-related immune differences and possible differences in
health-seeking behaviour.2–4 The finding of lower zoster dis-
ease burden among individuals of non-white ethnicity seen in
this study has been previously reported.4,11–14 This effect of
lower zoster incidence among individuals of non-white ethni-
city could be explained by persisting immunity to zoster in
later years because of late-onset varicella in individuals born
in the Caribbean or tropical countries,3,14,27,28 although
immigrants represent a heterogeneous group in terms of their
country of origin and age of arrival in the U.K. There was lit-
tle evidence of collinearity between ethnicity and immigration
status, and the finding of lower zoster incidence among those
of non-white ethnicity, independent of immigration status,
could perhaps be explained by social mixing patterns in
extended families leading to varicella contacts and boosting of
zoster immunity among older individuals.29 It is also possible
that zoster might be underdiagnosed if individuals of non-white
ethnicity who developed zoster were less likely to consult or less
likely to be diagnosed, but it seems implausible in view of the
large effect seen. The association of care home residence with
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higher zoster incidence was noted independent of age and
comorbidities. The effect of malnutrition on immune function
could also play an important role; previous research has sug-
gested that nearly one in three care home residents could be at
risk of malnutrition.30–32 The association of higher zoster inci-
dence with certain comorbidities and taking immunosuppres-
sive treatment has been previously reported.2,3,5,22,33 Similarly,
as reported previously, we also did not find any evidence of an
association of diabetes with zoster disease burden.22 The associ-
ation of social support, cohabitation or being married with zos-
ter incidence is conflicting: some studies have reported no
association with being married,5,12,14 individuals with a confi-
dant having lower12 or no effect14 on zoster incidence, whereas
another study reported higher zoster risk among individuals not
cohabiting.4 The unexpected finding of an independent associa-
tion of living alone and lower patient-level IMD with lower
incidence of first zoster episode could perhaps be because of a
higher occurrence of zoster among these social groups before
the age of 65 years and thus their exclusion from the current
study. However, there was no evidence for any appreciable dif-
ferences in patient-level IMD scores when the characteristics of
individuals with/without prior zoster history were compared.
In conclusion, this large population-based cohort study has
identified social factors associated with zoster incidence among
an older population in the U.K. Typically, older patients with
higher level of deprivation, those of non-white ethnicity,
immigrants and those living alone are at greater risk of infec-
tious diseases; interestingly, our study found these groups were
at lower risk of zoster. However, care home residence was asso-
ciated with higher zoster burden and it may be worth consider-
ing targeted vaccination of this group. Further research on the
risk of PHN in these social groups would also help inform vac-
cination policy. It will be interesting to determine in future
studies whether these social groups with higher zoster inci-
dence come forward for zoster vaccination.
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